Literature DB >> 29754292

Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.

Mustafa Hepokur1, Ahmet Murat Sarici2,3.   

Abstract

PURPOSE: This study aimed to compare the optical coherence tomography (OCT) findings of optic pathway glioma (OPG) patients (sporadic or secondary to neurofibromatosis type 1, NF1) with NF1 without OPG patients and healthy controls.
METHODS: This was a prospective, case-control study in which 27 patients (13 with OPGs and 14 with NF1 without OPGs) and 13 control subjects were included. The retinal nerve fiber layer (RNFL) thickness, macular thickness, and ganglion cell layer-inner plexiform layer (GCL-IPL) thickness findings measured using OCT and the results were compared between the groups.
RESULTS: The macular thickness was significantly lower in the OPG group than in the control group and the NF1 patients without OPGs group (p < 0.001). The GCL-IPL thickness was lower in OPG group than in the control group and the NF1 patients without OPG group (p < 0.001). The RNFL thickness was lower in the OPG group than in the control group and the NF1 patients without OPG group (p < 0.001). There was a statistically significantly negative correlation between the visual acuity (log of the minimum angle of resolution, logMAR) and all the other parameters (macular, RNFL, and GCL-IPL thicknesses). All the parameters were found to positively correlate with each other.
CONCLUSIONS: OCT measurements (macular thickness, RNFL, and GCL-IPL thicknesses) can be used to monitor the disease in those patients with suspected OPGs; however, this should be verified with a larger case series.

Entities:  

Keywords:  Neurofibromatosis type 1; Ocular oncology; Optic pathway glioma; Optical coherence tomography

Mesh:

Year:  2018        PMID: 29754292     DOI: 10.1007/s00417-018-4007-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  13 in total

1.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

Review 2.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.

Authors:  K N North; V Riccardi; C Samango-Sprouse; R Ferner; B Moore; E Legius; N Ratner; M B Denckla
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

Review 3.  Optic pathway gliomas.

Authors:  Robert A Avery; Michael J Fisher; Grant T Liu
Journal:  J Neuroophthalmol       Date:  2011-09       Impact factor: 3.042

4.  Investigation of retinal nerve fiber layer thickness in patients with neurofibromatosis-1.

Authors:  Pinar Topcu-Yilmaz; Burcu Kasim; Hayyam Kiratli
Journal:  Jpn J Ophthalmol       Date:  2014-02-04       Impact factor: 2.447

5.  Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.

Authors:  Lan Chang; Mays A El-Dairi; Tamiesha A Frempong; Erica L Burner; M Tariq Bhatti; Terri L Young; Fawn Leigh
Journal:  J AAPOS       Date:  2010-12       Impact factor: 1.220

Review 6.  Intracranial gliomas in neurofibromatosis type 1.

Authors:  R Listernick; J Charrow; D H Gutmann
Journal:  Am J Med Genet       Date:  1999-03-26

7.  Long-term outcome in children with gliomas of the anterior visual pathway.

Authors:  Sharon L Tow; Sidhartha Chandela; Neil R Miller; Anthony M Avellino
Journal:  Pediatr Neurol       Date:  2003-04       Impact factor: 3.372

8.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

Review 9.  Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.

Authors:  Sureka Thiagalingam; Maree Flaherty; Frank Billson; Kathryn North
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

Review 10.  Gliomas of the anterior visual pathway.

Authors:  J J Dutton
Journal:  Surv Ophthalmol       Date:  1994 Mar-Apr       Impact factor: 6.048

View more
  3 in total

Review 1.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

2.  Homonymous Retinal Ganglion Cell Layer Atrophy With Asymptomatic Optic Tract Glioma in Neurofibromatosis Type I.

Authors:  Amirah I Momen; Ryan T Muir; Carolina Barnett; Arun N E Sundaram
Journal:  Front Neurol       Date:  2020-04-15       Impact factor: 4.003

3.  Optical Coherence Tomography Identifies Visual Pathway Involvement Earlier than Visual Function Tests in Children with MRI-Verified Optic Pathway Gliomas.

Authors:  Urszula Arnljots; Maria Nilsson; Ulrika Sandvik; Ida Hed Myrberg; Daniel Martin Munoz; Klas Blomgren; Kerstin Hellgren
Journal:  Cancers (Basel)       Date:  2022-01-09       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.